News Release
CEI Senior Fellow Dr. Joel Zinberg named Special Assistant to the President for Economic Policy
Products
Free to Prosper: Health care
Wall Street Journal
A Thumb on the Scale for Wegovy
The Biden administration announced one more bit of executive overreach on its way out the door. On Nov. 26, the Centers for Medicare and Medicaid…
National Review
Telehealth Is Less Promising Than It First Seemed
A key issue facing Congress in its postelection, “lame duck” session is whether to extend regulatory flexibilities expiring at year end that make telehealth services more…
Study
Evaluating Telehealth
Executive Summary Why Did We Write This Report Telehealth—the use of remote audio and/or video technologies to provide health care services—has been promoted as…
News Release
Report: Telehealth flexibility deadline looms, but Congress needs better information to decide
Congress is poised to consider proposals that permanently or temporarily extend flexibilities for telehealth services enacted during the COVID-19 pandemic that are set to expire…
NPR
With Trump coming into power, the NIH is in the crosshairs
NPR cited CEI’s expert on changes in NIH “I do think you probably will see changes in NIH, as well as other public health agencies…
City Journal
Thumb on the Scale
Americans’ trust in the scientific establishment took another hit last week with the revelation that a prominent advocate of adolescent transgender treatments had …
The Washington Post
What Trump winning the election could mean for the CDC
The Washington Post cites CEI expert Joel Zinberg on the changing face of the CDC and what does (and doesn’t) belong in the agency: “Many…
CSPAN
VIDEO: Dr. Joel Zinberg joins CSPAN to discuss health care proposals from presidential candidates
Click here to read more.
Politico
Republicans have a post-pandemic plan for the scientific establishment
Politico cited CEI’s expert on a post-pandemic plan “You have the NIH in the sights of people who think there were big failures during the…
City Journal
The FTC Jettisons Economics—and Law
The Federal Trade Commission is stepping up its pursuit of its new favorite bogeyman: Pharmacy Benefit Managers. Two months ago, the FTC issued an …
Blog
Adam Smith on health policy
Today the Competitive Enterprise Institute published my OnPoint essay, “The Innovation Imperative: What Adam Smith Can Tell Us About Health.” This was adapted from…
Study
The Innovation Imperative
The Competitive Enterprise Institute recently celebrated its 40th anniversary in Edinburgh, Scotland. Edinburgh was chosen because the city was celebrating the 300th anniversary of the…
Politico
Republicans have a post-pandemic plan for the scientific establishment
Politico cites CEI expert post-pandemic plans “You have the NIH in the sights of people who think there were big failures during the pandemic and…
HeartLand Daily News
FDA Hid COVID Shot Side Effects—Congressional Report
Heartland Daily News cited CEI on COVID public health concerns Joel Zinberg, M.D., senior fellow at the Competitive Enterprise Institute and director of the Public…
Op-Eds
Often Wrong, Never in Doubt
Times have changed. Two years ago, tennis great Novak Djokovic could not play in the U.S. Open tournament. It was not because he had Covid-19…
The Wall Street Journal
The FTC Goes Evidence-Free
Through three years of Lina Khan’s leadership, the Federal Trade Commission has suffered an unprecedented streak of high-profile court defeats. That’s because the agency regularly makes…
Capital Matters
Corner Post: Helping Hold the Administrative State to Account
Much attention has been paid to the Supreme Court’s recent overrule of the 40-year-old Chevron decision in Loper Bright Enterprises v. Raimondo. Chevron had facilitated the expansion…
DC Journal
Rent Control Idea Undermines Affordable Housing in the Long Run
The Biden administration has called for imposing federal limits on rent increases. This is a profoundly misguided policy from an economic perspective, and since it lacks…
News Release
Biden Rent Control Idea is Bad Housing Policy
President Biden today issued a call to impose federal limits on rent increases nationwide. That idea would have many drawbacks, not just for landlords…
Blog
SCOTUS overrules Chevron Doctrine
The Supreme Court has spoken. “Chevron is overruled.” The 40-year-old Chevron decision had increased the level of judicial deference accorded to federal agencies to interpret…
News Release
Report: Federal Regulatory Agencies Abuse Power with Guidance Documents
A new report by Competitive Enterprise Institute and Paragon Health Institute scholar Dr. Joel Zinberg, Restoring Good Guidance Practices: How to restrain the administrative…
Study
Restoring Good Guidance Practices
Executive summary Federal agency guidance documents form a large and expanding part of the administrative state’s regulatory universe. These informal documents including memoranda, bulletins, and…
Penn Live
Harrisburg is taking a wrong approach to drug pricing | PennLive letters
CEI’s Joel Zinberg was cited in a Penn Live article on Pharmacy Benefit Managers: Joel Zinberg from the Competitive Enterprise Institute (CEI) explains, “PBMs enhance…
Politico
Biden’s got a plan to protect science from Trump
CEI’s Joel Zinberg was cited in Politico on the obstacles Trump faces with the NIH: Trump should have no illusions about what he’s up against,…
Blog
FDA makes lab test power play
The Food and Drug Administration has just released its long anticipated final rule that explicitly asserts its claim of authority to regulate laboratory-developed-tests (LDTs)—tests that are designed, manufactured,…
National Review
The Return of the Cadillac Tax?
Like the phoenix, a key piece of the Affordable Care Act has risen from the ashes, resurrected, believe it or not, by the Republican Study Committee…
City Journal
A Solution in Search of a Problem
In his State of the Union address, President Biden touted the drug-price controls in his Inflation Reduction Act (IRA). Though the price controls have yet…
National Review
Covid Vaccines: An Update on Balancing Risks and Benefits
A new large, multi-country study has confirmed what previous smaller studies found: Covid-19 vaccines have risks. In particular, the messenger RNA (mRNA) vaccines from Pfizer and…
City Journal
Ignoring the Science
A new CDC study reports that the first updated Covid-19 vaccine—the bivalent vaccine approved in fall 2022—was about 50 percent effective in blocking infection over a two-month…
The Federalist Society
Explainer 62 – FDA’s Regulation of Laboratory Developed Tests
CEI’s Joel Zinberg joined a podcast hosted by The Federalist Society for the Regulatory Transparency Project on the FDA’s regulation of laboratory developed tests:…
National Review
When Science Is Not Science
Just 22 percent of all adults and 41 percent of those 65 and older — the most vulnerable group — have received the updated 2023–24 Covid-19 vaccine.
Beritbart
Unholy Alliance Between the Left and Big Pharma Threatens More Big Government Intervention in Health Care
CEI’s Joel Zinberg is cited in Breitbart on the big government intervention in healthcare: Economic experts recognize that the very foundation of a free…
City Journal
A “Coordinated Campaign”
The Covid-19 pandemic revealed a split between those who believe that the government has broad authority to control every aspect of the economy and society…
Washington Times
Cutting-edge drugs could vanish under Biden’s unprecedented move to seize patents
CEI’s Dr. Joel Zinberg is cited in the Washington Times on the Biden Administration’s move to seize patents: Dr. Joel Zinberg, a senior fellow…
National Review
Another FDA Power Grab
The comment period for the Food and Drug Administration’s latest power grab has just concluded. Roughly 20,000 comments were submitted addressing the FDA’s proposed rule which…
Washington Times
Better late than never: New York Times finally admits school shutdowns hurt children
The New York Times has made a “startling” discovery. Its editorial board has recognized that “school closures that took 50 million children out of classrooms…
Daily Caller
‘Hidden Tax’: Biden Clocks In Biggest Regulatory Burden In Recent Memory, Report Says
Under President Joe Biden, the federal government completed 89 economically significant rules in 2022, defined as those with at least a $100 million economic impact,…
City Journal
Not-So-Affordable Care
In a 2022 book, Seemed Like a Good Idea, health economist Mark Pauly and his University of Pennsylvania coauthors describe how health-care policymakers “often rely on…
City Journal
Equity vs. Evidence
The U.S. Preventive Services Task Force—a volunteer panel of national experts in prevention and evidence-based medicine that makes recommendations for clinical preventive services such as…
National Review
Restricting Pharmacy Benefit Managers Could Decrease Competition and Increase Drug Costs
Congress is considering multiple bills that aim to restrict the ability of pharmacy benefit managers (PBMs) to negotiate discounts and rebates and to require the PBMs…
PCMA
Just the Facts: Research and Analysis Finds Anti-PBM Legislation Does Not Lower Prescription Drug Costs for Patients
PCMA cites CEI’s Joel Zinberg anti PBM legislation: “This policy would significantly change drug pricing and utilization and shift billions of dollars annually from patients…
Wall Street Journal
Court to FDA: Stop Playing Doctor
The Food and Drug Administration regulates pharmaceuticals, but it has no business playing doctor and giving you medical advice. That’s the message of a Sept.
News Release
Congressional Efforts to Regulate PBMs Risk Higher Drug Costs, Worse Health Outcomes for Patients
Pharmacy Benefit Managers (PBMs) are private businesses that developed in the free market to manage prescription drug benefits for health insurance plan sponsors. Nearly all…
Study
A Free Market Solution for Drug Distribution
Executive summary This paper describes and explains the function of Pharmacy Benefit Managers (PBMs) in the American health care economy. PBMs are private businesses that…
New York Post
Djokovic can compete in the US Open again — after Biden finally ended his unscientific travel ban
The US Open tennis tournament has begun in Queens, and one of the world’s best players will finally be allowed to compete again. Novak…
New York Post
Don’t believe doomsayers — new COVID outbreak is mild, and masks don’t help
COVID-19 cases are expected to rise this fall as new variants become more prevalent. And, as unfortunately expected, it’s already triggered demands by…
Fox News
New report reveals how CDC can be ready for the next pandemic
The Centers for Disease Control and Prevention has a new director, Dr. Mandy Cohen. Her predecessor, Dr. Rochelle Walensky, acknowledged CDC was…
Citation
Dr. Joel Zinberg discusses his report on refocusing and reforming the CDC after COVID-19 on C-SPAN’s Washington Journal
CEI Senior Fellow Joel Zinberg joined Washington Journal on August 11, 2023 to discuss new study from CEI and Paragon Health Institute which found…